Study on mechanism of naringin in alleviating cerebral ischemia/reperfusion injury based on DRP1/LRRK2/MCU axis.
10.19540/j.cnki.cjcmm.20250213.701
- Author:
Kai-Mei TAN
1
;
Hong-Yu ZENG
1
;
Feng QIU
1
;
Yun XIANG
1
;
Zi-Yang ZHOU
1
;
Da-Hua WU
2
;
Chang LEI
1
;
Hong-Qing ZHAO
1
;
Yu-Hong WANG
1
;
Xiu-Li ZHANG
1
Author Information
1. Science and Technology Innovation Center, Hunan University of Chinese Medicine Changsha 410208, China.
2. Affiliated Hospital of Hunan Academy of Chinese Medicine Changsha 410006, China.
- Publication Type:Journal Article
- Keywords:
DRP1/LRRK2/MCU signaling axis;
cerebral ischemia/reperfusion;
cortex;
mitochondrial fragmentation;
mitophagy;
naringin
- MeSH:
Animals;
Rats, Sprague-Dawley;
Reperfusion Injury/genetics*;
Flavanones/administration & dosage*;
Rats;
Dynamins/genetics*;
Male;
Brain Ischemia/genetics*;
Protein Serine-Threonine Kinases/genetics*;
Signal Transduction/drug effects*;
Humans;
Drugs, Chinese Herbal/administration & dosage*
- From:
China Journal of Chinese Materia Medica
2025;50(9):2484-2494
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to investigate the molecular mechanism by which naringin alleviates cerebral ischemia/reperfusion(CI/R) injury through DRP1/LRRK2/MCU signaling axis. A total of 60 SD rats were randomly divided into the sham group, the model group, the sodium Danshensu group, and low-, medium-, and high-dose(50, 100, and 200 mg·kg~(-1)) naringin groups, with 10 rats in each group. Except for the sham group, a transient middle cerebral artery occlusion/reperfusion(tMCAO/R) model was established in SD rats using the suture method. Longa 5-point scale was used to assess neurological deficits. 2,3,5-Triphenyl tetrazolium chloride(TTC) staining was used to detect the volume percentage of cerebral infarction in rats. Hematoxylin-eosin(HE) staining and Nissl staining were employed to assess neuronal structural alterations and the number of Nissl bodies in cortex, respectively. Western blot was used to determine the protein expression levels of B-cell lymphoma-2 gene(Bcl-2), Bcl-2-associated X protein(Bax), cleaved cysteine-aspartate protease-3(cleaved caspase-3), mitochondrial calcium uniporter(MCU), microtubule-associated protein 1 light chain 3(LC3), and P62. Mitochondrial structure and autophagy in cortical neurons were observed by transmission electron microscopy. Immunofluorescence assay was used to quantify the fluorescence intensities of MCU and mitochondrial calcium ion, as well as the co-localization of dynamin-related protein 1(DRP1) with leucine-rich repeat kinase 2(LRRK2) and translocase of outer mitochondrial membrane 20(TOMM20) with LC3 in cortical mitochondria. The results showed that compared with the model group, naringin significantly decreased the volume percentage of cerebral infarction and neurological deficit score in tMCAO/R rats, alleviated the structural damage and Nissl body loss of cortical neurons in tMCAO/R rats, inhibited autophagosomes in cortical neurons, and increased the average diameter of cortical mitochondria. The Western blot results showed that compared to the sham group, the model group exhibited increased levels of cleaved caspase-3, Bax, MCU, and the LC3Ⅱ/LC3Ⅰ ratio in the cortex and reduced protein levels of Bcl-2 and P62. However, naringin down-regulated the protein expression of cleaved caspase-3, Bax, MCU and the ratio of LC3Ⅱ/LC3Ⅰ ratio and up-regulated the expression of Bcl-2 and P62 proteins in cortical area. In addition, immunofluorescence analysis showed that compared with the model group, naringin and positive drug treatments significantly decreased the fluorescence intensities of MCU and mitochondrial calcium ion. Meanwhile, the co-localization of DRP1 with LRRK2 and TOMM20 with LC3 in cortical mitochondria was also decreased significantly after the intervention. These findings suggest that naringin can alleviate cortical neuronal damage in tMCAO/R rats by inhibiting DRP1/LRRK2/MCU-mediated mitochondrial fragmentation and the resultant excessive mitophagy.
